Comparison 16. Ginger versus zinc sulphate.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Pain score (VAS 0 to 10) | 1 | Mean Difference (IV, Fixed, 95% CI) | Totals not selected | |
1.1 Pain score 1st cycle | 1 | Mean Difference (IV, Fixed, 95% CI) | 0.0 [0.0, 0.0] | |
1.2 Pain score 2nd cycle | 1 | Mean Difference (IV, Fixed, 95% CI) | 0.0 [0.0, 0.0] | |
2 Adverse effects | 1 | Odds Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
2.1 First cycle | 1 | Odds Ratio (M‐H, Fixed, 95% CI) | 0.0 [0.0, 0.0] | |
2.2 Second cycle | 1 | Odds Ratio (M‐H, Fixed, 95% CI) | 0.0 [0.0, 0.0] |